“It’s a Way of Reparations”: Why Henrietta Lacks Settlement Matters for Bioethics & Racial Justice
By Amy Goodman,
Democracy Now!
| 08. 07. 2023
The family of Henrietta Lacks, a Black cancer patient whose cells were taken by Johns Hopkins University Hospital without her consent in 1951, has reached a deal over the unethical use of her cells with pharmaceutical company Thermo Fisher Scientific. Henrietta Lacks’s family has denounced the racist medical system that allowed the biotech company to make billions in profit from the “HeLa” cell line, which helped produce remedies for multiple diseases, including the first polio vaccine. Details of the settlement were not made public, but the plaintiffs celebrated the lawsuit’s resolution last Tuesday, on Henrietta Lack’s birthday. For more on the case and the history of medical racism in the United States, we speak with Dorothy Roberts, director of the University of Pennsylvania Program on Race, Science and Society. She is the author of several books, including Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-first Century. “What happened to Henrietta Lacks didn’t just happen to her. It’s part of a long history of experimentation and exploitation of Black people in biomedical research,” says Roberts...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...